A new role for an old player: Do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?

Journal of Autoimmunity

Volumn 31, Issue 3, 2008, Pages 301-305

  Mariño, Eliana ^a   Grey, Shane T ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmunity; B cells; CD8+ T cell; Diabetes

Indexed keywords

ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CELL MATURATION; CELL TYPE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTE SUBSETS; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS;

EID: 56349083164     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.001     Document Type: Article

References (41)

1. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 (2007) 887-892
2. Park Y., and Eisenbarth G.S. Genetic susceptibility factors of Type 1 diabetes in Asians. Diabetes Metab Res Rev 17 (2001) 2-11
3. Exner B.G., Groninger J.H., and Ildstad S.T. Bone marrow transplantation for therapy in autoimmune disease. Stem Cells 15 Suppl 1 (1997) 171-175 (discussion 175-6)
4. Herold K.C., Hagopian W., Auger J.A., Poumian-Ruiz E., Taylor L., Donaldson D., et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346 (2002) 1692-1698
5. Roep B.O., Atkinson M., and von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 4 (2004) 989-997
6. Silveira P.A., and Grey S.T. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol Metab 17 (2006) 128-135
7. Yu L., and Eisenbarth G.S. Chapter 10: Humoral Autoimmunity. In: Eisenbarth G.S. (Ed). Type I Diabetes: Molecular, Cellular and Clinical Immunology (2005), Springer
8. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435 (2005) 220-223
9. Martin S., Wolf-Eichbaum D., Duinkerken G., Scherbaum W.A., Kolb H., Noordzij J.G., et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345 (2001) 1036-1040
10. Serreze D.V., Chapman H.D., Varnum D.S., Hanson M.S., Reifsnyder P.C., Richard S.D., et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med 184 (1996) 2049-2053
11. Hu C.Y., Rodriguez-Pinto D., Du W., Ahuja A., Henegariu O., Wong F.S., et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117 (2007) 3857-3867
12. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., and Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161 (1998) 3912-3918
13. Tian J., Zekzer D., Lu Y., Dang H., and Kaufman D.L. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 176 (2006) 2654-2661
14. Falcone M., Lee J., Patstone G., Yeung B., and Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161 (1998) 1163-1168
15. Greeley S.A., Katsumata M., Yu L., Eisenbarth G.S., Moore D.J., Goodarzi H., et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8 (2002) 399-402
16. Harbers S.O., Crocker A., Catalano G., D'Agati V., Jung S., Desai D.D., et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 117 (2007) 1361-1369
17. Hulbert C., Riseili B., Rojas M., and Thomas J.W. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol 167 (2001) 5535-5538
18. Wong F.S., Wen L., Tang M., Ramanathan M., Visintin I., Daugherty J., et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53 (2004) 2581-2587
19. Noorchashm H., Lieu Y.K., Noorchashm N., Rostami S.Y., Greeley S.A., Schlachterman A., et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 163 (1999) 743-750
20. Serreze D.V., Chapman H.D., Varnum D.S., Gerling I., Leiter E.H., and Shultz L.D. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 158 (1997) 3978-3986
21. Katz J.D., Wang B., Haskins K., Benoist C., and Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74 (1993) 1089-1100
22. Benoist C., and Mathis D. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell 89 (1997) 1-3
23. Kagi D., Odermatt B., Seiler P., Zinkernagel R.M., Mak T.W., and Hengartner H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 186 (1997) 989-997
24. Itoh N., Imagawa A., Hanafusa T., Waguri M., Yamamoto K., Iwahashi H., et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186 (1997) 613-618
25. Hamilton-Williams E.E., Palmer S.E., Charlton B., and Slattery R.M. Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci U S A 100 (2003) 6688-6693
26. Mackay F., Sierro F., Grey S.T., and Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 8 (2005) 243-265
27. Hoglund P., Mintern J., Waltzinger C., Heath W., Benoist C., and Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189 (1999) 331-339
28. Mariño E., Batten M., Groom J., Walters S., Liuwantara D., Mackay F., et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57 (2008) 395-404
29. Amrani A., Verdaguer J., Anderson B., Utsugi T., Bou S., and Santamaria P. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest 103 (1999) 1201-1209
30. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., and Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406 (2000) 739-742
31. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111 (2003) 217-223
32. Han B., Serra P., Amrani A., Yamanouchi J., Maree A.F., Edelstein-Keshet L., et al. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 11 (2005) 645-652
33. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201 (2005) 139-148
34. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265-277
35. Brodie G.M., Wallberg M., Santamaria P., Wong F.S., and Green E.A. B cells promote intra-islet CD8+ cytotoxic T lymphocyte survival to enhance type 1 diabetes. Diabetes 57 (2008) 909-917
36. de Jersey J., Snelgrove S.L., Palmer S.E., Teteris S.A., Mullbacher A., Miller J.F., et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc Natl Acad Sci U S A 104 (2007) 1295-1300
37. Bennett S.R., Carbone F.R., Toy T., Miller J.F., and Heath W.R. B cells directly tolerize CD8(+) T cells. J Exp Med 188 (1998) 1977-1983
38. Martin F., and Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2 (2002) 323-335
39. Attanavanich K., and Kearney J.F. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 172 (2004) 803-811
40. Rolf J., Motta V., Duarte N., Lundholm M., Berntman E., Bergman M.L., et al. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol 174 (2005) 4821-4827
41. Noorchashm H., Moore D.J., Lieu Y.K., Noorchashm N., Schlachterman A., Song H.K., et al. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell Immunol 195 (1999) 75-79